NCT07778680

Brief Summary

Randomized Control Trial of AmDTx (new name DawnDTx) on waitlist patients waiting for first psychiatric consultation to determine if a digital mental health app can reduce PHQ8 and GAD7 scores during the waitlist period.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Feb 2025Dec 2026

Study Start

First participant enrolled

February 1, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 18, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 21, 2026

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

August 21, 2026

Status Verified

August 1, 2026

Enrollment Period

1.3 years

First QC Date

August 18, 2026

Last Update Submit

August 18, 2026

Conditions

Depression Anxiety DisorderAnxiety and Depression

Keywords

Digital Menal Health

Outcome Measures

Primary Outcomes (2)

  • GAD7

    GAD7

    8 weeks

  • PHQ8

    PHQ8

    8 weeks

Study Arms (2)

Active App

ACTIVE COMPARATOR

Actual AmDTx App

Other: Mobile App - AmDTx (New name DawnDTx)

Placebo

PLACEBO COMPARATOR

Placebo App

Other: Placebo App

Interventions

Mobile App - AmDTx (New name DawnDTx)OTHER

Mobile mental health app

Active App
Placebo AppOTHER

Placebo App

Placebo

Eligibility Criteria

Age13 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Waitlisted for outpatient psychosocial programming or psychiatric services at IMH or SGH
  • Age range: IMH: 13 and above; SGH: 21 and above
  • Language: Fluency in English (to complete assessments)
  • Understanding and willingness to comply with study requirements / capable of providing informed consent (e.g., autonomously or with guardian support)
  • Comfortable with smartphone or tablet, downloading and running the AmDTx platform, and at least periodic access to the internet.

You may not qualify if:

  • Any known practical factors that would preclude participation (e.g., extended absences) in the study.
  • Serious medical condition that precludes participation in this study.
  • Intellectual disability (as evidenced by attending a special school for intellectual disability)
  • Participation in another treatment/intervention study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Mental Health

Singapore, Singapore

Location

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2026

First Posted

August 21, 2026

Study Start

February 1, 2025

Primary Completion

May 19, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

August 21, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Study team can analyze results

Locations

SG(1)